Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Diabetes Care Market Size Forecast: How Large Could The Market Become By 2030?
The global diabetes care market demonstrated robust expansion recently, projecting a rise from $29.09 billion in 2025 to $31.63 billion in 2026, marking a compound annual growth rate of 8.7%. Factors contributing to this historical growth trajectory include a rising incidence of diabetes, expanded management within hospital settings, continued dependence on traditional finger-prick blood glucose monitoring, evolving lifestyle patterns, and demographic shifts towards an older population.
Diabetes care is poised for substantial expansion over the coming years, projecting a market valuation of $43.97 billion by 2030, driven by an 8.6% compound annual growth rate. This upward trajectory is fueled by the increasing prevalence of digital health innovations, the broader availability of connected devices, a growing preference for home-based care solutions, advancements in insulin delivery mechanisms, and a greater emphasis on patient empowerment in self-management. Key developments anticipated during this growth phase include a surge in the adoption of continuous glucose monitoring technology, the proliferation of at-home diabetes management services, expanded utilization of insulin pumps, the seamless integration of digital tools for diabetes care coordination, and a pronounced shift towards individualized treatment plans.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24206&type=smp
Diabetes Care Market Opportunity Drivers: What Is Creating New Revenue Potential?
The escalating prevalence of obesity is anticipated to be a key driver for the expansion of the diabetes care market. Obesity, characterized by a significantly high body mass index (BMI), is on the rise, largely attributable to increasingly sedentary habits and the pervasive accessibility of highly processed, energy-dense, yet nutritionally sparse foods. This dietary pattern, combined with reduced physical activity, creates an energy imbalance. The diabetes care sector is instrumental in mitigating the impact of these rising obesity figures by advocating for healthier living patterns, enhancing blood sugar control, and supporting weight management through sophisticated interventions like insulin treatments and real-time glucose monitoring devices. As an illustration, data from the Office for Health Improvement and Disparities in the UK revealed that in England, the proportion of adults aged 18 and above who were either overweight or obese climbed from 64.0% in the 2022-2023 period to an estimated 64.5% in 2023-2024, as reported in May 2025. Consequently, the growing obesity epidemic directly fuels the growth trajectory of the diabetes care market.
Diabetes Care Market Segment Landscape: Which Areas Lead Market Development?
The diabetes care market covered in this report is segmented –
1) By Product Type: Glucose Monitoring Devices, Insulin Pumps
2) By Diabetes Type: Type 2 Diabetes, Type 1 Diabetes, Other Diabetes Type
3) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Care Settings, Other End Users
Subsegments:
1) By Glucose Monitoring Devices: Blood Glucose Monitoring (BGM), Continuous Glucose Monitoring (CGM), Flash Glucose Monitoring (FGM)
2) By Insulin Pumps: Patch Pump, Tethered Pump, Implanted Insulin Pump
Diabetes Care Market Innovation Trends Driving Future Development
In the competitive landscape of diabetes management solutions, leading corporations are actively pursuing the creation of cutting-edge advancements, exemplified by automated insulin delivery (AID) systems, which aim to refine glycemic control through the seamless integration of continuous glucose monitoring (CGM) devices with sophisticated insulin pumps, enabling instantaneous therapeutic modifications. Specifically, an automated insulin delivery system represents a sophisticated technological fusion of a continuous glucose monitor and an insulin pump, designed to autonomously regulate insulin administration based on immediate glucose readings, thereby enhancing the overall efficacy of diabetes care. Demonstrating this trend, Tandem Diabetes Care Inc., a prominent American medical device firm specializing in diabetes therapeutics, unveiled the Tandem Mobi in February 2024, a groundbreaking device recognized as the world’s most diminutive yet resilient automated insulin delivery platform for individuals managing diabetes. This pioneering apparatus features a discreet, tubed insulin pump that offers comprehensive management capabilities through a smartphone application, liberating users from dependence on conventional remote control units and empowering them with greater autonomy in their diabetes regimen. The Tandem Mobi is engineered to be waterproof and easily rechargeable, and it synergizes with the Dexcom continuous glucose monitoring system to facilitate automated insulin delivery, leveraging Tandem’s established Control-IQ technological framework.
Diabetes Care Market Industry Leaders And Market Competition
Major companies operating in the diabetes care market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals Inc., Terumo Corporation, Dexcom Inc., Dr. Reddy’s Laboratories Limited, SD Biosensor Inc., Insulet Corporation, Tandem Diabetes Care Inc., LifeScan Inc., Ypsomed AG, Ascensia Diabetes Care Holdings AG, B. Braun Melsungen AG, Bionime Corporation, Arkray Inc., ACON Laboratories Inc., ViCentra B.V., Microtech Medical Ltd., Sinocare Inc., MicroGene Diagnostic Systems Pvt. Ltd.
Access The Complete Diabetes Care Market Report:
https://www.thebusinessresearchcompany.com/report/diabetes-care-global-market-report
Diabetes Care Market Geographic Analysis: Where Is Demand Growing The Fastest?
North Americawas the largest region in the diabetes care market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
